Connect with us

Health

AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study

A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.

The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against imicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.

For all the latest headlines follow our Google News channel online or via the app.

After a three-dose course of the vaccine, neutralizing levels against omicron were similar to those against the virus’s delta variant after two doses, the company added.

The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.

Read more:

Omicron hospitalization risk is far below delta’s in two studies

Pfizer pill becomes first US-authorized home COVID-19 treatment

No country can boost its way out of pandemic: WHO chief

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Europe: Report highlights direct link between pandemic and childhood obesity

The COVID-19 pandemic has led to increased obesity in school-aged children in Europe, the World Health Organization (WHO) office for the region said in a new report issued on Wednesday, sounding the alarm for action.

Continue Reading

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Continue Reading

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Continue Reading

Trending